Clinical severity of NF2 depends on the type and position of the NF2 alteration, with ependymomas and meningiomas more often arising in patients with truncating NF2 mutations compared to milder clinical phenotypes in patients with missense or mosaic mutations [11, 19]. The gene discussed is NF2; the disease is ependymoma.